SLE, RA & Behçet’s Criteria for MRCP Part 1

TL;DR

For MRCP Part 1, remembering classification criteria is far more valuable than memorising long diagnostic descriptions. List: Criteria for SLE/RA/Behcet’s is a frequent examination theme because questions often present clinical features and laboratory findings that fulfil recognised classification systems rather than asking for the criteria directly. This guide summarises the highest-yield criteria, common traps, and practical revision strategies for rapid recall.

Why this matters

Classification criteria appear repeatedly in MRCP Part 1 because they integrate clinical medicine, immunology and rheumatology into realistic patient scenarios. Candidates are rarely asked to reproduce every criterion verbatim. Instead, they are expected to recognise combinations of symptoms, examination findings and investigations that fulfil accepted diagnostic frameworks.

Among autoimmune diseases, systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and Behçet's disease are particularly important because they involve multisystem presentations with overlapping differentials.

Understanding these criteria also improves interpretation of laboratory investigations such as ANA, anti-dsDNA, RF, anti-CCP and inflammatory markers.

For a broader syllabus overview, see the MRCP Part 1 overview:https://www.crackmedicine.com/mrcp-part-1/

Core sections

The five most tested subtopics

1. 2019 EULAR/ACR SLE Classification Criteria

2. 2010 ACR/EULAR Rheumatoid Arthritis Criteria

3. International Criteria for Behçet's Disease (ICBD)

4. Autoantibody interpretation

5. Important differential diagnoses

Quick comparison table

Disease	Key Autoantibodies	Hallmark Features	Important Exam Pearl
SLE	ANA, anti-dsDNA, anti-Sm	Multisystem autoimmune disease	Positive ANA is an entry criterion
RA	RF, Anti-CCP	Symmetrical inflammatory polyarthritis	Anti-CCP is more specific
Behçet's	No specific antibody	Oral ulcers, genital ulcers, uveitis	Diagnosis is clinical

1. SLE Classification Criteria (2019 EULAR/ACR)

The modern SLE criteria begin with one mandatory requirement.

Entry criterion

A patient must have:

• Positive ANA ≥1:80

Without a positive ANA, the patient cannot be classified as SLE using these criteria.

Once ANA positivity is confirmed, weighted clinical and immunological criteria are added. A total score of 10 or more points classifies SLE.

High-yield domains

Clinical

• Fever

• Non-scarring alopecia

• Oral ulcers

• Acute cutaneous lupus

• Synovitis

• Serositis

• Proteinuria

• Seizures

• Delirium

• Psychosis

• Haemolytic anaemia

• Leukopenia

• Thrombocytopenia

Immunological

• Low C3/C4

• Anti-dsDNA

• Anti-Sm antibodies

• Antiphospholipid antibodies

Exam pearl

Anti-dsDNA titres correlate with disease activity, particularly lupus nephritis.

2. Rheumatoid Arthritis Classification Criteria (2010 ACR/EULAR)

RA classification uses a scoring system out of 10.

A total score of 6 or more supports classification as definite RA.

Four scoring domains

A. Joint involvement

More small joints receive higher scores than large joints.

B. Serology

• RF

• Anti-CCP

High-positive antibodies score more than low-positive results.

C. Acute phase reactants

• ESR

• CRP

Either abnormal result contributes points.

D. Duration

Symptoms lasting more than six weeks increase the score.

High-yield memory aid

Think:

Joints + Antibodies + Inflammation + Duration

3. Behçet's Disease (ICBD)

Unlike SLE and RA, Behçet's disease has no diagnostic blood test.

Diagnosis depends upon clinical findings.

Common features include:

• Recurrent oral ulcers

• Genital ulcers

• Uveitis

• Skin lesions

• Neurological involvement

• Vascular thrombosis

• Positive pathergy test

The International Criteria for Behçet's Disease assigns weighted scores, with a total of 4 points or more supporting diagnosis.

Most important examination feature

Recurrent oral ulceration is the commonest presentation.

4. Autoantibodies you must know

ANA

• Sensitive

• Not specific

• Entry criterion for SLE

Anti-dsDNA

• Highly specific

• Correlates with lupus nephritis

Anti-Sm

• Highly specific

• Less sensitive

Anti-CCP

• Most specific antibody for RA

• Predicts erosive disease

Rheumatoid factor

• Less specific

• May occur in chronic infections and elderly patients

5. Differential diagnoses commonly tested

Candidates should distinguish these disorders from similar conditions.

SLE

Differentiate from

• Drug-induced lupus

• Mixed connective tissue disease

• Antiphospholipid syndrome

• Viral arthritis

RA

Differentiate from

• Psoriatic arthritis

• Osteoarthritis

• Reactive arthritis

• Viral polyarthritis

Behçet's

Differentiate from

• Crohn's disease

• HSV infection

• Reactive arthritis

• Systemic vasculitis

High-yield revision checklist

Learn these 10 points

1. ANA positivity is mandatory before applying SLE criteria.

2. Anti-Sm is highly specific for SLE.

3. Anti-dsDNA correlates with lupus nephritis.

4. Anti-CCP is more specific than RF.

5. RA requires persistent inflammatory arthritis.

6. Small joints score higher than large joints in RA.

7. Behçet's diagnosis remains clinical.

8. Oral ulcers alone do not diagnose Behçet's disease.

9. Pathergy testing is supportive but not essential.

10. Classification criteria are not identical to clinical diagnosis.

Practical examples / mini-cases

Mini-case

A 28-year-old woman presents with:

• Photosensitive rash

• Oral ulcers

• Proteinuria

• Positive ANA

• Positive anti-dsDNA

• Low complement

What is the most likely diagnosis?

Answer: Systemic lupus erythematosus.

Explanation

The patient satisfies the ANA entry criterion together with multiple weighted clinical and immunological features. This is a classic MRCP-style presentation.

Practical study-tip checklist

✔ Memorise the entry criterion for SLE.

✔ Revise RA scoring domains rather than individual numbers.

✔ Remember anti-CCP is more specific than RF.

✔ Learn Behçet's as a clinical diagnosis.

✔ Compare similar autoimmune diseases side by side.

✔ Practise mixed rheumatology questions rather than isolated diseases.

Use the Free MRCP MCQs to reinforce these concepts:https://www.crackmedicine.com/qbank/

For structured teaching, explore the MRCP lectures:https://www.crackmedicine.com/lectures/

Common pitfalls

• Confusing diagnostic criteria with classification criteria.

• Assuming a positive ANA alone confirms SLE.

• Believing rheumatoid factor is highly specific.

• Forgetting that Behçet's disease has no single diagnostic blood test.

• Ignoring disease duration in RA classification.

FAQs

Is ANA enough to diagnose SLE?

No. ANA is an entry criterion in the 2019 EULAR/ACR classification system, but additional weighted clinical and immunological features are required to reach the classification threshold.

Which antibody is most specific for rheumatoid arthritis?

Anti-CCP antibodies are more specific than rheumatoid factor and are associated with more aggressive, erosive disease.

Does every patient with Behçet's disease have a positive pathergy test?

No. A positive pathergy test supports the diagnosis but is not required. Many patients fulfil the International Criteria without it.

Are classification criteria identical to diagnostic criteria?

No. Classification criteria are primarily designed for research consistency but are commonly tested in MRCP examinations because they standardise disease recognition.

Ready to start?

Mastering classification criteria is one of the quickest ways to improve rheumatology scores in MRCP Part 1. After reviewing this guide, reinforce your knowledge with timed practice questions, revisit autoimmune disease lectures, and compare similar connective tissue disorders side by side. You may also find our related article on Drug Rashes: SJS vs TEN vs DRESS useful for differentiating autoimmune disease from severe drug reactions.

Sources

1. MRCP(UK) Examination Blueprint. https://www.mrcpuk.org/

2. European Alliance of Associations for Rheumatology (EULAR). https://www.eular.org/

3. American College of Rheumatology. https://rheumatology.org/

4. Aringer M, et al. 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases.

5. Aletaha D, et al. 2010 Rheumatoid Arthritis Classification Criteria. Annals of the Rheumatic Diseases.

6. International Team for the Revision of the International Criteria for Behçet's Disease. Clinical and Experimental Rheumatology.